MERRIMACK PHARMACEUTICALS IN (MACK) Stock News

MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q1 2024

Merrimack Pharmaceuticals just reported results for the first quarter of 2024.

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q4 2023

Merrimack Pharmaceuticals just reported results for the fourth quarter of 2023.

Merrimack Receives $225 Million Milestone Payment from Ipsen

Merrimack Reports Full Year 2023 Financial Results

Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

$2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Mentions: TRMB F UNP

Merrimack Reports Third Quarter 2023 Financial Results

Merrimack Reports Second Quarter 2023 Financial Results

Merrimack Reports First Quarter 2023 Financial Results

3 Stocks Insiders Are Buying: Triumph Financial And More

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Mentions: JELD TFIN

Upstart (UPST) Stock Sinks on Gloomy Forecast

Upstart (UPST) stock is sliding lower on Wednesday following a poor performance in the third quarter of 2022 and a weak outlook.

Mentions: UPST BBBY DIS

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning!

Mentions: JNCE STBX SWVL LYLT ...

Merrimack Reports Full Year 2022 Financial Results

Merrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Plan